Development of a small implantable right ventricular assist device

Kiyotaka Fukamachi, David J. Horvath, Alex L. Massiello, Yoshio Ootaki, Keiji Kamohara, Masatoshi Akiyama, Firas Zahr, Michael W. Kopcak, Raymond Dessoffy, Ji Feng Chen, Stephen Benefit, Leonard A R Golding

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

The purpose of this program is to design, develop, and clinically evaluate a new, implantable right ventricular assist device (RVAD) that can be used as a component of an implantable biventricular assist device for patients with severe biventricular heart failure. The initial phase of this program resulted in a prototype RVAD, named DexAide, a modified version of the CorAide left ventricular assist device. In vitro testing was performed in a stand-alone circuit and in a true RVAD mode to evaluate pump performance. Pump flow and power were measured under various afterload and pump speed conditions. The pump performance requirements of 2 to 6 l/min and a pressure rise of 20 to 60 mm Hg were successfully met with pump speeds between 1,800 and 3,200 rpm. The nominal design point of 4 l/min and 40 mm Hg pressure rise was achieved at 2,450 ± 70 rpm with a power consumption of 3.0 ± 0.2 W. The initial in vitro testing met the design criteria for the new DexAide RVAD. Initial in vivo testing is under way, which will be followed by preclinical readiness testing and a pilot clinical trial in this 5-year program.

Original languageEnglish (US)
Pages (from-to)730-735
Number of pages6
JournalASAIO Journal
Volume51
Issue number6
DOIs
StatePublished - Nov 2005
Externally publishedYes

Fingerprint

Heart-Assist Devices
Pumps
Testing
Left ventricular assist devices
Pressure
Electric power utilization
Heart Failure
Clinical Trials
Equipment and Supplies
Networks (circuits)

ASJC Scopus subject areas

  • Biophysics
  • Bioengineering

Cite this

Fukamachi, K., Horvath, D. J., Massiello, A. L., Ootaki, Y., Kamohara, K., Akiyama, M., ... Golding, L. A. R. (2005). Development of a small implantable right ventricular assist device. ASAIO Journal, 51(6), 730-735. https://doi.org/10.1097/01.mat.0000181031.66900.b6

Development of a small implantable right ventricular assist device. / Fukamachi, Kiyotaka; Horvath, David J.; Massiello, Alex L.; Ootaki, Yoshio; Kamohara, Keiji; Akiyama, Masatoshi; Zahr, Firas; Kopcak, Michael W.; Dessoffy, Raymond; Chen, Ji Feng; Benefit, Stephen; Golding, Leonard A R.

In: ASAIO Journal, Vol. 51, No. 6, 11.2005, p. 730-735.

Research output: Contribution to journalArticle

Fukamachi, K, Horvath, DJ, Massiello, AL, Ootaki, Y, Kamohara, K, Akiyama, M, Zahr, F, Kopcak, MW, Dessoffy, R, Chen, JF, Benefit, S & Golding, LAR 2005, 'Development of a small implantable right ventricular assist device', ASAIO Journal, vol. 51, no. 6, pp. 730-735. https://doi.org/10.1097/01.mat.0000181031.66900.b6
Fukamachi K, Horvath DJ, Massiello AL, Ootaki Y, Kamohara K, Akiyama M et al. Development of a small implantable right ventricular assist device. ASAIO Journal. 2005 Nov;51(6):730-735. https://doi.org/10.1097/01.mat.0000181031.66900.b6
Fukamachi, Kiyotaka ; Horvath, David J. ; Massiello, Alex L. ; Ootaki, Yoshio ; Kamohara, Keiji ; Akiyama, Masatoshi ; Zahr, Firas ; Kopcak, Michael W. ; Dessoffy, Raymond ; Chen, Ji Feng ; Benefit, Stephen ; Golding, Leonard A R. / Development of a small implantable right ventricular assist device. In: ASAIO Journal. 2005 ; Vol. 51, No. 6. pp. 730-735.
@article{7eec420536ad4f03bf4d48015e536473,
title = "Development of a small implantable right ventricular assist device",
abstract = "The purpose of this program is to design, develop, and clinically evaluate a new, implantable right ventricular assist device (RVAD) that can be used as a component of an implantable biventricular assist device for patients with severe biventricular heart failure. The initial phase of this program resulted in a prototype RVAD, named DexAide, a modified version of the CorAide left ventricular assist device. In vitro testing was performed in a stand-alone circuit and in a true RVAD mode to evaluate pump performance. Pump flow and power were measured under various afterload and pump speed conditions. The pump performance requirements of 2 to 6 l/min and a pressure rise of 20 to 60 mm Hg were successfully met with pump speeds between 1,800 and 3,200 rpm. The nominal design point of 4 l/min and 40 mm Hg pressure rise was achieved at 2,450 ± 70 rpm with a power consumption of 3.0 ± 0.2 W. The initial in vitro testing met the design criteria for the new DexAide RVAD. Initial in vivo testing is under way, which will be followed by preclinical readiness testing and a pilot clinical trial in this 5-year program.",
author = "Kiyotaka Fukamachi and Horvath, {David J.} and Massiello, {Alex L.} and Yoshio Ootaki and Keiji Kamohara and Masatoshi Akiyama and Firas Zahr and Kopcak, {Michael W.} and Raymond Dessoffy and Chen, {Ji Feng} and Stephen Benefit and Golding, {Leonard A R}",
year = "2005",
month = "11",
doi = "10.1097/01.mat.0000181031.66900.b6",
language = "English (US)",
volume = "51",
pages = "730--735",
journal = "ASAIO Journal",
issn = "1058-2916",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Development of a small implantable right ventricular assist device

AU - Fukamachi, Kiyotaka

AU - Horvath, David J.

AU - Massiello, Alex L.

AU - Ootaki, Yoshio

AU - Kamohara, Keiji

AU - Akiyama, Masatoshi

AU - Zahr, Firas

AU - Kopcak, Michael W.

AU - Dessoffy, Raymond

AU - Chen, Ji Feng

AU - Benefit, Stephen

AU - Golding, Leonard A R

PY - 2005/11

Y1 - 2005/11

N2 - The purpose of this program is to design, develop, and clinically evaluate a new, implantable right ventricular assist device (RVAD) that can be used as a component of an implantable biventricular assist device for patients with severe biventricular heart failure. The initial phase of this program resulted in a prototype RVAD, named DexAide, a modified version of the CorAide left ventricular assist device. In vitro testing was performed in a stand-alone circuit and in a true RVAD mode to evaluate pump performance. Pump flow and power were measured under various afterload and pump speed conditions. The pump performance requirements of 2 to 6 l/min and a pressure rise of 20 to 60 mm Hg were successfully met with pump speeds between 1,800 and 3,200 rpm. The nominal design point of 4 l/min and 40 mm Hg pressure rise was achieved at 2,450 ± 70 rpm with a power consumption of 3.0 ± 0.2 W. The initial in vitro testing met the design criteria for the new DexAide RVAD. Initial in vivo testing is under way, which will be followed by preclinical readiness testing and a pilot clinical trial in this 5-year program.

AB - The purpose of this program is to design, develop, and clinically evaluate a new, implantable right ventricular assist device (RVAD) that can be used as a component of an implantable biventricular assist device for patients with severe biventricular heart failure. The initial phase of this program resulted in a prototype RVAD, named DexAide, a modified version of the CorAide left ventricular assist device. In vitro testing was performed in a stand-alone circuit and in a true RVAD mode to evaluate pump performance. Pump flow and power were measured under various afterload and pump speed conditions. The pump performance requirements of 2 to 6 l/min and a pressure rise of 20 to 60 mm Hg were successfully met with pump speeds between 1,800 and 3,200 rpm. The nominal design point of 4 l/min and 40 mm Hg pressure rise was achieved at 2,450 ± 70 rpm with a power consumption of 3.0 ± 0.2 W. The initial in vitro testing met the design criteria for the new DexAide RVAD. Initial in vivo testing is under way, which will be followed by preclinical readiness testing and a pilot clinical trial in this 5-year program.

UR - http://www.scopus.com/inward/record.url?scp=33644874425&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644874425&partnerID=8YFLogxK

U2 - 10.1097/01.mat.0000181031.66900.b6

DO - 10.1097/01.mat.0000181031.66900.b6

M3 - Article

C2 - 16340358

AN - SCOPUS:33644874425

VL - 51

SP - 730

EP - 735

JO - ASAIO Journal

JF - ASAIO Journal

SN - 1058-2916

IS - 6

ER -